StockWatch
·
Pharmaceuticals
Insider Trading26 Jun 2026, 02:44 pm

Hester Biosciences Closes Trading Window for Q2 FY27 Results

AI Summary

Hester Biosciences Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations and the company's internal code of conduct. The trading window will be shut from July 1, 2026, and will reopen 48 hours after the financial results for the quarter ended June 30, 2026, are made public. This measure is standard practice to prevent insider trading during periods when material non-public information may be available.

Key Highlights

  • Trading window closed from July 1, 2026.
  • Closure is for Q2 FY27 financial results announcement.
  • Aims to prevent insider trading.
  • Reopening 48 hours post results publication.